A 46-year-old man was admitted in our hospital with hypoglycemia; his FPG was 43 mg/mL. Five years earlier, he underwent simultaneous surgeries for an adrenal adenoma, a benign Leydig cell tumor (LCT), and a malignant lymphoma. Based on the laboratory results, he was diagnosed as congenital adrenal hyperplasia (CAH) due to nonclassical 21-hydroxylase deficiency (21-OHD). On immunohistochemistry analysis using the antibody against adrenal-specific 11β-hydroxylase antibody, the LCT showed both properties as a testicular cell and as an adrenal cell. The genetic background of 21-OHD might contribute to the development of malignant lymphoma. Such as a case of LCT and malignant lymphoma in a patient with 21-OHD seems to be rare. © 2009 The Japanese Society of Internal Medicine.
CITATION STYLE
Inaba, H., Suzuki, S., Shigematsu, S., Shinomiya, K., Ohfusa, H., Shimojo, Y., … Hashizume, K. (2009). Leydig cell tumor and malignant lymphoma in a patient with nonclassical 21-hydroxylase deficiency. Internal Medicine, 48(8), 601–605. https://doi.org/10.2169/internalmedicine.48.1733
Mendeley helps you to discover research relevant for your work.